GGrantIndex
Sort

172,184 grants matching inflammation

Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates

$721,178
Ryan Eugene Temel · University Of Kentucky · R01 · FY2017 · HL

Chikungunya Virus Replication and Pathogenesis

$721,175
Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI

Immunopathogenesis of HIV-associated pulmonary hypertension

$721,172
Karen A Norris · University Of Georgia · R01 · FY2019 · HL

Dual drug delivery to lung/blood interface in respiratory infections.

$721,126
Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2023 · HL

Integrated Multi-Scale Analysis of Tumor and Host Response to Therapy

$721,122
Shan X. Wang · University Of Southern California · U54 · FY2011 · CA

Animal models of eye diseases

$721,120
Sheldon Miller · National Eye Institute · ZIA · FY2011 · EY

Epidemiology of CHD of men aged 40+ in US, Hawaii, Japan

$721,090
Akira Sekikawa · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL

Atherogenic Mechanisms of Electronic Nicotine Delivery Systems

$721,087
Sanjay Srivastava · University Of Louisville · R01 · FY2021 · HL

HIV Nef Function and Early Events in Macrophage and Microglia Infection

$721,084
Maribeth V. Eiden · National Institute Of Mental Health · ZIA · FY2009 · MH

Specialized Pro-Resolving Mediators in Asthma

$721,062
Bruce D Levy · Brigham And Women'S Hospital · R01 · FY2024 · HL

Reversal of HIV latency by METH and Inflammation

$721,059
Jonathan Karn · Case Western Reserve University · R01 · FY2020 · DA

Development of P2Y Receptor Ligands

$721,055
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK

Integrated Reward-Inflammation Model of First Onset of Major Depression in Adolescence

$721,036
Lauren Bersh Alloy · Temple Univ Of The Commonwealth · R01 · FY2022 · MH

Transcutaneous Energy Transmission System for Fully Implantable VADs

$721,018
Aaron Richard McCabe · Minnetronix, Inc. · R44 · FY2015 · HL

Establishing the contributions of monogenic etiologies to hidradenitis suppurativapathogenesis

$720,985
Lynn Petukhova · Columbia University Health Sciences · R01 · FY2023 · AR

Novel pathways controlling macrophage inflammation and resolution in atherosclerosis

$720,981
Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2021 · HL

Novel pathways controlling macrophage inflammation and resolution in atherosclerosis

$720,981
Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2022 · HL

Novel pathways controlling macrophage inflammation and resolution in atherosclerosis

$720,981
Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2020 · HL

Impact of hypothalamic gliosis on appetite regulation and obesity risk in children

$720,978
Ellen A Schur · University Of Washington · R01 · FY2021 · DK

Post-TB epigenetic scars' impact on long-term inflammation, immunity and mortality

$720,939
Andrew R Dinardo · Baylor College Of Medicine · R01 · FY2025 · AI

Development of GCPII inhibitors for the treatment of age-related cognitive disorders

$720,931
Takashi Tsukamoto · Johns Hopkins University · R01 · FY2020 · AG

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGENS

$720,910
Immune Disease Institute, Inc. · R37 · FY2005 · CA

HIV Status and Incidence and Outcomes of Heart Failure

$720,906
Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2018 · HL

Molecular Imaging of G-Protein-Coupled Receptors for Drug Development

$720,904
Stanley J Opella · University Of California, San Diego · R01 · FY2013 · EB

Partial Antagonists of IRE1 RNase--'PAIR's--to treat Type 1 Diabetes

$720,903
Feroz R Papa · University Of California, San Francisco · U01 · FY2022 · DK